Cargando…
Higher serum galactose-deficient immunoglobulin A1 concentration is associated with stronger mesangial cellular inflammatory response and more severe histologic findings in immunoglobulin A nephropathy
BACKGROUND: Galactose-deficient immunoglobulin A1 (Gd-IgA1) is known to play a key role in the pathogenesis of IgA nephropathy (IgAN). We aimed to evaluate whether serum Gd-IgA1 is associated with in vitro activation of mesangial cells in individual patients and how this affects the clinical and his...
Autores principales: | Nguyen, Celine, König, Katrin, Tam, Frederick W K, Hopfer, Helmut, Molyneux, Karen, Binet, Francoise-Isabelle, Kim, Min Jeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452211/ https://www.ncbi.nlm.nih.gov/pubmed/30976401 http://dx.doi.org/10.1093/ckj/sfy068 |
Ejemplares similares
-
MicroRNAs: a new avenue to understand, investigate and treat immunoglobulin A nephropathy?
por: Selvaskandan, Haresh, et al.
Publicado: (2018) -
The investigative burden of membranous nephropathy in the UK
por: Hamilton, Patrick, et al.
Publicado: (2019) -
Rituximab-induced serum sickness in the treatment of idiopathic membranous nephropathy
por: Cheong, Jamie, et al.
Publicado: (2018) -
Treatment pattern in patients with idiopathic membranous nephropathy—practices in Sweden at the start of the millennium
por: Lönnbro-Widgren, Jennie, et al.
Publicado: (2016) -
Idiopathic membranous nephropathy in patients with diabetes mellitus: a diagnostic and therapeutic quandary!
por: Bhadauria, Dharmendra, et al.
Publicado: (2018)